首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1447615

器官晶片市場類型[產品（肝臟、肺臟、心臟、腎臟）、服務]、材料（PDMS、聚合物、玻璃）、模型類型（單一、多重器官）、應用（藥物發現、毒性測試、個人化醫療），最終用戶，全球預測2024-2032

Organs-on-chips Market-Type [Product (Liver, Lung, Heart, Kidney), Service], Material (PDMS, Polymer, Glass), Model Type (Single, Multi-organ), Application (Drug Discovery, Toxicity Testing, Personalized Medicine), End-user, Global Forecast 2024-2032

出版日期: 2024年01月24日 | 出版商:

Global Market Insights Inc. | 英文 207 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於對動物試驗替代品的需求不斷成長、技術進步以及研發投資不斷增加，預計 2024 年至 2032 年全球器官晶片市場的CAGR將超過 32.2%。

據善待動物組織 (PETA) 稱，英國各地對動物進行了近 7,600 萬次手術。隨著組織的目標是減少這一數字並儘量減少對動物測試的依賴，預計市場將會成長。器官晶片為模仿人體器官的生理和機械特性提供了一個有前途的平台，有助於徹底改變藥物開發、毒性測試和疾病建模。

器官晶片市場根據類型、材料、模型類型、應用、最終用戶和地區進行分類。

由於其多功能性、生物相容性和可調特性，預計聚合物材料領域從 2024 年到 2032 年將錄得強勁的CAGR。聚二甲基矽氧烷（PDMS）和聚氨酯等聚合物由於能夠有效複製人體組織的微環境，已成為製造器官晶片的熱門選擇。此外，包括軟光刻和微流體在內的聚合物製造技術的進步，進一步推動了基於聚合物的器官晶片平台在製藥和生物技術行業的採用。

毒性測試應用領域預計到 2032 年將產生大量收入，因為它們提供了比傳統動物測試方法更準確和更具預測性的替代方案。這些微流體裝置使研究人員能夠模擬藥物、化學物質和人體組織之間的複雜相互作用，從而促進潛在毒性問題的早期檢測並最大限度地減少對動物模型的依賴。隨著世界各地監管機構強調在藥物開發中減少和取代動物測試，預計未來幾年對用於毒性測試的器官晶片的需求將激增。

在領先製藥公司、學術研究機構和支持性監管框架的推動下，到 2032 年，歐洲器官晶片市場規模將大幅擴大。英國、德國和法國正在大力投資加速研究和商業化工作。此外，歐洲藥品管理局（EMA）等監管機構為促進採用替代檢測方法而採取的舉措正在促進晶片器官平台在該地區的廣泛接受。

產業生態系統分析
產業影響力
- 成長動力
  - 慢性病盛行率增加
  - 對個人化醫療的需求不斷增加
  - 器官晶片技術的不斷進步
  - 擴大器官晶片模型在生物醫學應用的使用
- 產業陷阱與挑戰
  - 實施器官晶片技術的挑戰與複雜性
  - 監管障礙
成長潛力分析
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀錶板

第 5 章：市場估計與預測：按類型，2018 - 2032

主要趨勢
產品
- 肝臟晶片
- 肺晶片
- 晶片上的心臟
- 腎臟晶片
- 其他產品
服務

第 6 章：市場估計與預測：按材料分類，2018 - 2032 年

主要趨勢
聚二甲基矽氧烷 (PDMS)
聚合物
玻璃

第 7 章：市場估計與預測：按車型類型，2018 年 - 2032 年

主要趨勢
單一器官模型
多重器官模型

第 8 章：器官晶片市場估計與預測：按應用，2018 年 - 2032 年

主要趨勢
藥物發現
毒性測試
疾病建模
個人化醫療
其他應用

第 9 章：市場估計與預測：按最終用戶分類，2018 年 - 2032 年

主要趨勢
製藥和生物技術公司
學術及研究機構
其他最終用戶

第 10 章：器官晶片市場估計與預測：按地區，2018 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 11 章：公司簡介

Altis Biosystems
AlveoliX AG
Axosim
Bi/ond Solutions B.V
Cherry Biotech
CN-Bio
Emulate, Inc.
Hesperos, Inc.
Insphero
MesoBioTech
Mimetas B.V.
Nortis Inc.
React4Life
TARA Biosystems (Valo Health)
TissUse GmbH

簡介目錄

Product Code: 7964

The global organs-on-chips market is anticipated to witness more than 32.2% CAGR from 2024 to 2032 driven by the increasing demand for alternatives to animal testing, advancements in technology, and rising investments in R&D.

According to PETA, nearly 76 million procedures are done on animals across the UK. As organizations aim to reduce this number and minimize the dependency on animal testing, the market is anticipated to grow. As organs-on-chips offer a promising platform for mimicking the physiological and mechanical properties of human organs, thus helping in revolutionizing drug development, toxicity testing, and disease modeling.

The organs-on-chips market is classified based on type, material, model type, application, end-user, and region.

The polymer material segment is predicted to record strong CAGR from 2024 to 2032, owing to its versatility, biocompatibility, and tunable properties. Polymers such as polydimethylsiloxane (PDMS) and polyurethane have emerged as popular choices for manufacturing organs-on-chips due to their ability to replicate the microenvironment of human tissues effectively. Moreover, advancements in polymer fabrication techniques, including soft lithography and microfluidics, are further fueling the adoption of polymer-based organs-on-chips platforms across pharmaceutical and biotechnology industries.

The toxicity testing application segment is expected to generate massive revenue by 2032 as they offer a more accurate and predictive alternative to traditional animal testing methods. These microfluidic devices enable researchers to simulate the complex interactions between drugs, chemicals, and human tissues, thereby facilitating early detection of potential toxicity issues and minimizing the reliance on animal models. With regulatory agencies worldwide emphasizing the reduction and replacement of animal testing in drug development, the demand for organs-on-chips for toxicity testing is expected to surge in the coming years.

Europe organs-on-chips market size will expand significantly through 2032 driven by the presence of leading pharmaceutical companies, academic research institutes, and supportive regulatory frameworks. United Kingdom, Germany, and France are significantly investing to accelerate research and commercialization efforts. Additionally, initiatives by regulatory bodies such as the European Medicines Agency (EMA) to promote the adoption of alternative testing methods are fostering the widespread acceptance of organs-on-chips platforms across the region.

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data validation
1.5 Data sources
- 1.5.1 Primary
- 1.5.2 Secondary
  - 1.5.2.1 Paid sources
  - 1.5.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic disease
  - 3.2.1.2 Increasing demand for personalized medicine
  - 3.2.1.3 Growing advancement in organ-on-chip technology
  - 3.2.1.4 Expanding use of organ-on-chip models in biomedical applications
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Challenges and intricacies in implementing organ-on-chip techniques
  - 3.2.2.2 Regulatory obstacles
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Product
- 5.2.1 Liver-on-chip
- 5.2.2 Lung-on-chip
- 5.2.3 Heart-on-chip
- 5.2.4 Kidney-on-chip
- 5.2.5 Other products
5.3 Service

Chapter 6 Market Estimates and Forecast, By Material, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Polydimethylsiloxane (PDMS)
6.3 Polymer
6.4 Glass

Chapter 7 Market Estimates and Forecast, By Model Type, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Single-organ model
7.3 Multi-organ model

Chapter 8 Organ on Chip Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Drug discovery
8.3 Toxicity testing
8.4 Disease modeling
8.5 Personalized medicine
8.6 Other applications

Chapter 9 Market Estimates and Forecast, By End-User, 2018 - 2032 (USD Million)

9.1 Key trends
9.2 Pharmaceutical and biotechnology companies
9.3 Academic and research institutes
9.4 Other end-users

Chapter 10 Organ on Chip Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 Rest of Middle East and Africa